Stem cells may one day be used to make cells and tissues for the therapy of diseases such as Parkinson's disease, Alzheimer's disease, spinal cord injury, heart disease, diabetes, and arthritis.

the verdict

SUPPORTED

the evidence backs this

Recorded sources

5 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that stem cells may one day be used to make cells and tissues for the therapy of diseases such as Parkinson's disease, Alzheimer's disease, spinal cord injury, heart disease, diabetes, and arthritis?

Yes. Current scientific literature and regenerative medicine reviews widely support the promising therapeutic potential of stem cells for generating replacement cells and tissues to target conditions like neurodegenerative diseases and tissue injuries.

Verdict: SUPPORTED · 5 sources for, 0 against · Last checked 3 Oct 2026

The analysis

The retrieved papers strongly support the claim that stem cells and regenerative medicine are being researched and developed for the future therapy of degenerative diseases such as Parkinson's, Alzheimer's, and other tissue-level injuries, with numerous preclinical and clinical investigations pointing toward this potential.

Evidence for · 5

Neural Stem Cell-Derived Extracellular Vesicles: The Next Frontier in Neurological and Neurodegenerative Diseases.

2026

Get citation

HE, M. & C, C. (2026). Neural Stem Cell-Derived Extracellular Vesicles: The Next Frontier in Neurological and Neurodegenerative Diseases.. doi.org. https://doi.org/10.1007/s12015-026-11129-1

See more details

More for · 4

Regenerative medicine for neurodegenerative diseases: history, strategies, and clinical advances.

2026

Get citation

J, L., H, D., P, H., W, Z., Y, G., Z, Y., & X, L. (2026). Regenerative medicine for neurodegenerative diseases: history, strategies, and clinical advances.. doi.org. https://doi.org/10.1016/j.trsl.2026.08.005

Synergistic effects of tanshinone IIA and mesenchymal stem cells on neuroprotection, cardiovascular repair, tissue regeneration, muscle protein synthesis, and gut microbiota modulation across neurodegenerative, cardiovascular, and regenerative disease models.

2026

Get citation

W, W., H, G., & Y, W. (2026). Synergistic effects of tanshinone IIA and mesenchymal stem cells on neuroprotection, cardiovascular repair, tissue regeneration, muscle protein synthesis, and gut microbiota modulation across neurodegenerative, cardiovascular, and regenerative disease models.. doi.org. https://doi.org/10.3389/fcell.2026.1883952

Neural Stem Cells in Multiple Sclerosis: A Comprehensive Review of Preclinical and Clinical Evidence for CNS Repair and Translational Hurdles.

2026

Get citation

E, R., A, A., A, G., & A, M. (2026). Neural Stem Cells in Multiple Sclerosis: A Comprehensive Review of Preclinical and Clinical Evidence for CNS Repair and Translational Hurdles.. doi.org. https://doi.org/10.1007/s12010-026-05865-w

Histological and Tissue-Level Outcomes of Stem Cell Therapies in Neurodegenerative Disorders: A Systematic Review.

2026

Get citation

H, F., LA, S., & DR, S. (2026). Histological and Tissue-Level Outcomes of Stem Cell Therapies in Neurodegenerative Disorders: A Systematic Review.. doi.org. https://doi.org/10.1002/ca.70147

What does the evidence say?

Receipt History

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.

Check your own claim

Challenge the receipt

I have a source that contradicts this verdict I have a source that supports it No source: request a receipt review Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work